Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients

Stefano Nicolè; Massimiliano Lanzafame; Emanuela Lattuada; Dora Luise; Marta Vecchi; Evelina Tacconelli; Sandro Vento

doi:10.1080/23744235.2019.1609078

Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients

Stefano Nicolè, Massimiliano Lanzafame, Emanuela Lattuada, Dora Luise, Marta Vecchi, Evelina Tacconelli, Sandro Vento

Department of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	615-617
Number of pages	3
Journal	Infectious Diseases
Volume	51
Issue number	8
DOIs	https://doi.org/10.1080/23744235.2019.1609078
Publication status	Published - Aug 3 2019

ASJC Scopus subject areas

General Immunology and Microbiology
Microbiology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/23744235.2019.1609078

Cite this

@article{36390427253243508ca51d3e35c44045,

title = "Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients",

author = "Stefano Nicol{\`e} and Massimiliano Lanzafame and Emanuela Lattuada and Dora Luise and Marta Vecchi and Evelina Tacconelli and Sandro Vento",

year = "2019",

month = aug,

day = "3",

doi = "10.1080/23744235.2019.1609078",

language = "English",

volume = "51",

pages = "615--617",

journal = "Infectious Diseases",

issn = "2374-4235",

publisher = "Taylor and Francis",

number = "8",

}

TY - JOUR

T1 - Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients

AU - Nicolè, Stefano

AU - Lanzafame, Massimiliano

AU - Lattuada, Emanuela

AU - Luise, Dora

AU - Vecchi, Marta

AU - Tacconelli, Evelina

AU - Vento, Sandro

PY - 2019/8/3

Y1 - 2019/8/3

UR - http://www.scopus.com/inward/record.url?scp=85065728089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065728089&partnerID=8YFLogxK

U2 - 10.1080/23744235.2019.1609078

DO - 10.1080/23744235.2019.1609078

M3 - Letter

AN - SCOPUS:85065728089

SN - 2374-4235

VL - 51

SP - 615

EP - 617

JO - Infectious Diseases

JF - Infectious Diseases

IS - 8

ER -

Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this